{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:23:00Z","timestamp":1787862180115,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd012144.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000}}],"reference-count":71,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012144.pub3","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T06:39:12Z","timestamp":1674715152000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antithrombotic treatment after stroke due to intracerebral haemorrhage"],"prefix":"10.1002","volume":"2023","author":[{"given":"Alexia","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Medical School; The University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine, UNSW; Sydney Australia"},{"name":"The George Institute for Global Health; Beijing China"},{"name":"Department of Neurology; Shanghai East Hospital, School of Medicine, Tongji University; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Stephen","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute; The University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Morten","family":"R\u00f8nning","sequence":"additional","affiliation":[{"name":"Department of Neurology; Akershus University Hospital; L\u00f8renskog Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S","family":"Anderson","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, Faculty of Medicine; University of New South Wales; Sydney Australia"},{"name":"The George Institute China at Peking University Health Science Center; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J","family":"Hankey","sequence":"additional","affiliation":[{"name":"Medical School, Faculty of Health and Medical Sciences; The University of Western Australia; Perth Australia"},{"name":"Perron Institute for Neurological and Translational Science; Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; The University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD012144.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13063-015-0898-4","article-title":"Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation (APACHE-AF): study protocol for a randomised controlled trial","volume":"16","author":"Van Nieuwenhuizen","year":"2015","journal-title":"Trials"},{"issue":"23","key":"10.1002\/14651858.CD012144.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/BF01727666","article-title":"Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral haemorrhage","volume":"66","author":"Dickmann","year":"1988","journal-title":"Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0004|cit4","unstructured":"Shoamanesh A Sharma M Dowlatshahi D Pikula A Smith EE Gladstone DJ Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the NASPAF-ICH randomized trial International Stroke Conference, Session A28 - Late-Breaking Science Oral Abstracts II Los Angeles 2020"},{"issue":"6","key":"10.1002\/14651858.CD012144.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/NRL.0b013e3181a93bac","article-title":"Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage","volume":"15","author":"Orken","year":"2009","journal-title":"Neurologist"},{"issue":"3","key":"10.1002\/14651858.CD012144.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/STROKEAHA.119.023855","article-title":"Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage: subgroup analysis of the PICASSO Trial","volume":"51","author":"Kim","year":"2020","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD012144.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1474-4422(18)30128-5","article-title":"Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial","volume":"17","author":"Kim","year":"2018","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD012144.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000511574","article-title":"PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients - PREVENTIHS Study: a randomized controlled trial and a systematic review and meta-analysis","volume":"83","author":"Paciaroni","year":"2020","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"106534","DOI":"10.1016\/j.clineuro.2021.106534","article-title":"Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: a double blind placebo controlled multicenter study","volume":"202","author":"Qian","year":"2021","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-018-2542-6","article-title":"The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial","volume":"19","author":"Al-Shahi Salman","year":"2018","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD012144.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(19)30184-X","article-title":"Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial","volume":"18","author":"Al-Shahi Salman","year":"2019","journal-title":"Lancet Neurology"},{"issue":"10191","key":"10.1002\/14651858.CD012144.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1016\/S0140-6736(19)30840-2","article-title":"Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial","volume":"393","author":"RESTART Collaboration","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD012144.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7.","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","author":"SoSTART Collaboration","year":"2021","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD012144.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/jnnp.54.5.466","article-title":"Early heparin therapy in patients with spontaneous intracerebral haemorrhage","volume":"54","author":"Boeer","year":"1991","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9066","key":"10.1002\/14651858.CD012144.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke; CAST (Chinese Acute Stroke Trial) Collaborative Group","volume":"349","author":"CAST (Chinese Acute Stroke Trial) Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0016|cit16","unstructured":"A multi-center, randomized, double-blind, placebo-controlled clinical study of SXHYXN combined with ZLHXTY in the treatment of cerebral hemorrhage http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=63798"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0017|cit17","first-page":"236","article-title":"Safety of venous thromboembolism prophylaxis in intracranial hemorrhage patients with external ventricular drains","volume":"45","author":"Frontera","year":"2014","journal-title":"Stroke"},{"issue":"9065","key":"10.1002\/14651858.CD012144.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stoke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"Abstract 50","DOI":"10.1161\/str.49.suppl_1.50","article-title":"Restarting therapeutic anticoagulation in patients with intracerebral hemorrhage and mechanical heart valves","volume":"49 Suppl 1","author":"Kuramatsu","year":"2018","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/2012.9.JNS112286","article-title":"Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage","volume":"118","author":"Li","year":"2013","journal-title":"Journal of Neurosurgery"},{"issue":"10","key":"10.1002\/14651858.CD012144.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/jamaneurol.2021.2956","article-title":"Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial","volume":"78","author":"Al-Shahi Salman","year":"2021","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0022|cit22","first-page":"38","article-title":"Safety of prophylactic heparin in acute intracerebral haemorrhage: post-hoc analysis of the INTERACT2 study","volume":"9 Suppl 1","author":"Venturelli","year":"2014","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD012144.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11547-013-0328-1","article-title":"Outcomes of antiplatelet therapy for haemorrhage patients after thrombolysis: a prospective study based on susceptibility-weighted imaging","volume":"119","author":"Yan","year":"2014","journal-title":"La Radiologica Medica"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ahj.2017.08.017","article-title":"Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: rationale and design of the ELDERCARE-AF study","volume":"194","author":"Okumura","year":"2017","journal-title":"American Heart Journal"},{"issue":"25","key":"10.1002\/14651858.CD012144.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"3122-35","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0027|cit27","unstructured":"REstart or STop Antithrombotic Randomised Trial in France (RESTART-Fr) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02966119"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0028|cit28","unstructured":"STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage (STATICH) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03186729"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0029|cit29","unstructured":"Avoiding Anticoagulation After IntraCerebral Haemorrhage (A3ICH) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03243175"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0030|cit30","unstructured":"Anticoagulation for stroke prevention and recovery after ICH (ASPIRE) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03907046"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0031|cit31","unstructured":"EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation (ENRICH-AF) Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0032|cit32","unstructured":"Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe (ASPIRING) - pilot phase https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04522102"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0033|cit33","unstructured":"Early-start antiplatelet treatment after neurosurgery in patients with spontaneous intracerebral hemorrhage https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04820972"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/2396987318770127","article-title":"Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): objectives and design of a randomised clinical trial and an observational study","volume":"3 Suppl 1","author":"Haas","year":"2018","journal-title":"European Stroke Journal"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Greenberg","year":"2015","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists' (ATT) Collaboration","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2020-323079","article-title":"Longer term stroke risk in intracerebral haemorrhage survivors","volume":"91","author":"Banerjee","year":"2020","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0038|cit38","unstructured":"Benz AP Johansson I Dewilde WJ Lopes RD Mehran R Sartori S Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials European Heart Journal - Cardiovascular Pharmacotherapy 10.1093\/ehjcvp\/pvab044"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1747493020968424","article-title":"Canadian stroke best practice recommendations: nanagement of spontaneous intracerebral hemorrhage, 7th edition update 2020","volume":"16","author":"Shoamanesh","year":"2021","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/STROKEAHA.118.024449","article-title":"Five-year risk of major ischemic and hemorrhagic events after intracerebral hemorrhage","volume":"50","author":"Casolla","year":"2019","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.STR.0000106480.76217.6F","article-title":"Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial","volume":"35","author":"Chapman","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2214-109X(20)30069-3","article-title":"Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0.5 million Chinese adults","volume":"8","author":"Chen","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/jcpt.13377","article-title":"Efficacy and safety of restarting antiplatelet therapy for patients with spontaneous intracranial haemorrhage: a systematic review and meta-analysis","volume":"46","author":"Cheng","year":"2021","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/svn-2020-000433","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of intracerebral haemorrhage","volume":"5","author":"Cao","year":"2020","journal-title":"Stroke and Vascular Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0045|cit45","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2017.11.009","article-title":"Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: a meta-analysis of cohort studies","volume":"384","author":"Ding","year":"2018","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","article-title":"Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline","volume":"4","author":"Klijn","year":"2019","journal-title":"European Stroke Journal"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"International Journal of Stroke"},{"issue":"2","key":"10.1002\/14651858.CD012144.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/STROKEAHA.121.037633","article-title":"Higher risk of ischemic stroke after an intracerebral hemorrhage than in general population: a cohort study from the United Kingdom","volume":"53","author":"Gaist","year":"2022","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0051|cit51","unstructured":"GRADEpro Guideline Development Tool McMaster University 2015"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0053|cit53","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"3-4","key":"10.1002\/14651858.CD012144.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000065661","article-title":"Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies","volume":"14","author":"Keir","year":"2002","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/WNL.0000000000004235","article-title":"Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation","volume":"89","author":"Korompoki","year":"2017","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1474-4422(21)00075-2","article-title":"Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies","volume":"20","author":"Li","year":"2021","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamaneurol.2021.0925","article-title":"Association between intracerebral hemorrhage and subsequent arterial ischemic events in participants from 4 population-based cohort studies","volume":"78","author":"Murthy","year":"2021","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0058|cit58","volume-title":"Royal College of Physicians","author":"Intercollegiate Stroke Working Party","year":"2016"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/STROKEAHA.121.038331","article-title":"Risk of cerebrovascular events in intracerebral hemorrhage survivors with atrial fibrillation: a nationwide cohort study","volume":"53","author":"Nielsen","year":"2022","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1538-7836.2011.04241.x","article-title":"Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies","volume":"9","author":"Paciaroni","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD012144.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1161\/STROKEAHA.114.006202","article-title":"Variation in restarting antithrombotic drugs at hospital discharge after ICH","volume":"45","author":"Pasquini","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1474-4422(18)30128-5","article-title":"Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial","volume":"17","author":"Kim","year":"2018","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD012144.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and metaanalysis","volume":"85","author":"Poon","year":"2014","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0064|cit64","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","article-title":"Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study","volume":"46","author":"Samarasekera","year":"2015","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1745-6215-12-101","article-title":"The International Stroke Trial database","volume":"12","author":"Sandercock","year":"2011","journal-title":"Trials"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0067|cit67","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N on behalf of the Cochrane GRADEing Methods Group Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD012144.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000024.pub5","article-title":"Anticoagulants for acute ischaemic stroke","author":"Wang","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012144.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"e0234957","DOI":"10.1371\/journal.pone.0234957","article-title":"Venous thromboembolism prevention in intracerebral hemorrhage: a systematic review and network meta-analysis","volume":"15","author":"YogendrakumarI","year":"2020","journal-title":"PLOS One"},{"issue":"4","key":"10.1002\/14651858.CD012144.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012144","article-title":"Antithrombotic treatment after intracerebral haemorrhage","author":"Perry","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012144.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012144.pub2","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","author":"Perry","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T05:50:25Z","timestamp":1754459425000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012144.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012144.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}